These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 34628868)

  • 21. Direct oral anticoagulants versus vitamin K antagonists in the treatment of left ventricular thrombosis: a systematic review and meta-analysis.
    Condello F; Maurina M; Chiarito M; Sturla M; Terzi R; Fazzari F; Sanz-Sanchez J; Cannata F; Condorelli G; Stefanini GG
    Minerva Cardiol Angiol; 2022 Dec; 70(6):666-676. PubMed ID: 35080357
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Direct oral anticoagulants for the treatment of left ventricular thrombosis: an updated systematic review and meta-analysis.
    Serenelli M; Pavasini R; Vitali F; Tonet E; Cantone A; Di Ienno L; Pompei G; Bertini M; Campo G
    J Cardiovasc Med (Hagerstown); 2022 Oct; 23(10):672-677. PubMed ID: 36099074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical Benefit of Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients with Atrial Fibrillation and Bioprosthetic Heart Valves.
    Russo V; Carbone A; Attena E; Rago A; Mazzone C; Proietti R; Parisi V; Scotti A; Nigro G; Golino P; D'Onofrio A
    Clin Ther; 2019 Dec; 41(12):2549-2557. PubMed ID: 31735436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Role of Direct Oral Anticoagulants Versus Vitamin K Antagonists in the Treatment of Left Ventricular Thrombi: A Meta-Analysis and Systematic Review.
    Al-Abcha A; Herzallah K; Saleh Y; Mujer M; Abdelkarim O; Abdelnabi M; Almaghraby A; Abela GS
    Am J Cardiovasc Drugs; 2021 Jul; 21(4):435-441. PubMed ID: 33354748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitamin K Antagonists and Direct Oral Anticoagulants in Nonagenarian Patients With Atrial Fibrillation.
    Raposeiras-Roubín S; Alonso Rodríguez D; Camacho Freire SJ; Abu-Assi E; Cobas-Paz R; Rodríguez Pascual C; García Comesaña J; González-Carrero López A; Cubelos Fernández N; López-Masjuán Ríos Á; Cespón-Fernández M; Muñoz-Pousa I; Caneiro-Queija B; Rodríguez Albarrán A; Castañera SÁ; Guillén JV; Carpintero Vara A; Barreiro Pardal C; Domínguez-Erquicia P; Domínguez-Rodríguez LM; Díaz Fernández JF; Fernández Vázquez F; Iñíguez-Romo A
    J Am Med Dir Assoc; 2020 Mar; 21(3):367-373.e1. PubMed ID: 31753740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of non-vitamin K antagonist oral anticoagulants for the management of left ventricular thrombus.
    Li S; Deng Y; Tong Y; Xiong Q; Hu J; Jiang X; He T; Liu L; Chen H
    Clin Cardiol; 2021 Jun; 44(6):754-760. PubMed ID: 33797773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical profile of direct oral anticoagulants versus vitamin K anticoagulants in octogenarians with atrial fibrillation: a multicentre propensity score matched real-world cohort study.
    Russo V; Attena E; Di Maio M; Mazzone C; Carbone A; Parisi V; Rago A; D'Onofrio A; Golino P; Nigro G
    J Thromb Thrombolysis; 2020 Jan; 49(1):42-53. PubMed ID: 31385163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Direct oral anticoagulants to treat left ventricular thrombus-A systematic review and meta-analysis: ELECTRAM investigators.
    Shah S; Shah K; Turagam MK; Sharma A; Natale A; Lakkireddy D; Garg J
    J Cardiovasc Electrophysiol; 2021 Jun; 32(6):1764-1771. PubMed ID: 33772939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of direct oral anticoagulants versus vitamin K antagonists or warfarin in patients with left ventricular thrombus outcomes: A systematic review and meta-analysis.
    da Silva Ferreira H; Lima Lopes J; Augusto J; Simões J; Roque D; Faria D; Ferreira J; Fialho I; Beringuilho M; Morais H; Ferreira AR; Morais J; Morais C
    Rev Port Cardiol; 2023 Jan; 42(1):63-70. PubMed ID: 36370988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Direct Oral Anticoagulation Versus Warfarin in Left Ventricular Thrombus: Pooled Analysis of Randomized Controlled Trials.
    Sahlén AO; Jiang H; Lau YH; Cuenza L; Cader FA; Al-Omary M; Surunchupakorn P; Ho KH; Sung J; Lee D; Honda S; Tan Wei Chieh J; Yap J
    J Clin Pharmacol; 2023 Oct; 63(10):1101-1107. PubMed ID: 37139934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the safety and efficacy of direct oral anticoagulants compared with vitamin-k antagonists in the treatment of left ventricular thrombosis. A systematic review and meta-analysis.
    Mehrpooya M; Barakzehi MR; Nikoobakhsh M
    Heart Lung; 2024; 67():121-136. PubMed ID: 38754272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Direct Oral Anticoagulants vs Vitamin K Antagonists in Left Ventricular Thrombi: A Systematic Review and Meta-analysis.
    Michael F; Natt N; Shurrab M
    CJC Open; 2021 Sep; 3(9):1169-1181. PubMed ID: 34712941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Direct oral anticoagulants (DOAC) versus vitamin K antagonist in left ventricular thrombus: An updated meta-analysis.
    Shrestha DB; Dawadi S; Dhakal B; Shtembari J; Patel T; Shaikh R; Bodziock GM; Shantha G; Trankle CR; Patel NK
    Health Sci Rep; 2023 Nov; 6(11):e1736. PubMed ID: 38028683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of Direct Oral Anticoagulants in the Treatment of Left Ventricular Thrombus: Systematic Review of Current Literature.
    Kajy M; Shokr M; Ramappa P
    Am J Ther; 2020; 27(6):e584-e590. PubMed ID: 30730331
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Direct oral anticoagulants compared to vitamin K antagonist for the management of left ventricular thrombus.
    Iqbal H; Straw S; Craven TP; Stirling K; Wheatcroft SB; Witte KK
    ESC Heart Fail; 2020 Oct; 7(5):2032-2041. PubMed ID: 32583975
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of direct oral anticoagulants for treatment of left ventricular thrombus; a systematic review.
    Kumar D; Warsha FNU; Helmstetter N; Gupta V
    Acta Cardiol; 2021 Oct; 76(8):825-829. PubMed ID: 33970796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trial sequential analysis of efficacy and safety of direct oral anticoagulants and vitamin K antagonists against left ventricular thrombus.
    Kitano T; Nabeshima Y; Kataoka M; Takeuchi M
    Sci Rep; 2023 Aug; 13(1):13203. PubMed ID: 37580355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Direct Anticoagulants Versus Vitamin K Antagonists in Patients Aged 80 Years or Older With Atrial Fibrillation in a "Real-world" Nationwide Registry: Insights From the FANTASIIA Study.
    Ortiz MR; Muñiz J; Esteve-Pastor MA; Marín F; Roldán I; Cequier A; Martínez-Sellés M; Saldivar HG; Bertomeu V; Anguita M
    J Cardiovasc Pharmacol Ther; 2020 Jul; 25(4):316-323. PubMed ID: 32228180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rivaroxaban versus Vitamin K Antagonists (warfarin) based on the triple therapy for left ventricular thrombus after ST-Elevation myocardial infarction.
    Zhang Z; Si D; Zhang Q; Qu M; Yu M; Jiang Z; Li D; Yang P; Zhang W
    Heart Vessels; 2022 Mar; 37(3):374-384. PubMed ID: 34420077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of novel oral anticoagulants compared to vitamin K antagonists (warfarin) in patients with left ventricular thrombus after acute myocardial infarction.
    Jones DA; Wright P; Alizadeh MA; Fhadil S; Rathod KS; Guttmann O; Knight C; Timmis A; Baumbach A; Wragg A; Mathur A; Antoniou S
    Eur Heart J Cardiovasc Pharmacother; 2021 Sep; 7(5):398-404. PubMed ID: 32730627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.